Research analysts at Citizens Jmp initiated coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a "mkt outperform" rating and a $58.00 price target on the stock. Citizens Jmp's price objective points to a potential upside of 20.36% from the company's current price.
A number of other equities research analysts have also issued reports on HNGE. Evercore ISI began coverage on Hinge Health in a research report on Monday, June 16th. They issued an "outperform" rating and a $50.00 price target for the company. Barclays raised their target price on Hinge Health from $43.00 to $51.00 and gave the stock an "overweight" rating in a research note on Monday. Bank of America started coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $42.00 price target on the stock. Truist Financial began coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $48.00 price objective for the company. Finally, Morgan Stanley assumed coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "overweight" rating and a $46.00 target price on the stock. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Hinge Health has an average rating of "Moderate Buy" and an average price target of $49.36.
Check Out Our Latest Stock Analysis on HNGE
Hinge Health Stock Up 1.2%
NYSE HNGE traded up $0.55 during trading hours on Monday, hitting $48.19. 830,694 shares of the company's stock traded hands, compared to its average volume of 1,045,669. Hinge Health has a 52-week low of $33.42 and a 52-week high of $52.16.
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
See Also
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
